SARS-CoV-2 NSP12 (RdRP) 抗体 (C-Term)
SARS-CoV-2 RdRP
适用: SARS Coronavirus-2 (SARS-CoV-2)
WB, ELISA
宿主: 兔
Polyclonal
unconjugated
1 image
(1 reference)-
- 抗原 See all SARS-CoV-2 NSP12 (RdRP) (SARS-CoV-2 RdRP) 抗体
- SARS-CoV-2 NSP12 (RdRP) (SARS-CoV-2 RdRP) (SARS-CoV-2 RNA-dependent RNA Polymerase (NSP12) (SARS-CoV-2 RdRP))
-
抗原表位
- C-Term
- 适用
- SARS Coronavirus-2 (SARS-CoV-2)
-
宿主
- 兔
-
克隆类型
- 多克隆
-
标记
- This SARS-CoV-2 NSP12 (RdRP) antibody is un-conjugated
- 应用范围
- Western Blotting (WB), ELISA
- 纯化方法
- SARS-CoV-2 (COVID-19) NSP12 antibody is affinity chromatography purified via peptide column.
- 免疫原
- Anti-SARS-CoV-2 (COVID-19) NSP12 antibody was raised against a peptide corresponding to 16 amino acids near the carboxyl terminus of SARS-CoV-2 (COVID-19) NSP12 protein. The immunogen is located within the last 50 amino acids of the SARS-CoV-2 (COVID-19) NSP12 protein.
- 亚型
- IgG
-
anti-SARS-CoV-2 RNA-dependent RNA Polymerase (NSP12) (SARS-CoV-2 RdRP) (C-Term) antibody
SARS-CoV-2 RdRP 适用: SARS Coronavirus-2 (SARS-CoV-2) WB 宿主: 山羊 Polyclonal unconjugated
-
- 应用备注
-
WB: 1-2 μ,g/mL
Antibody validated: SARS-CoV-2 (COVID-19) NSP12 antibody can detect 2 ng of free peptide at 1 ?g/mL in ELISA. It can detect SARS-CoV-2 NSP12 recombinant protein by ELISA and WB. All other applications and species not yet tested. - 限制
- 仅限研究用
-
- 状态
- Liquid
- 浓度
- 1 mg/mL
- 缓冲液
- SARS-CoV-2 (COVID-19) NSP12 antibody is supplied in PBS containing 0.02 % sodium azide.
- 储存液
- Sodium azide
- 注意事项
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- 储存条件
- -20 °C,4 °C
- 储存方法
- SARS-CoV-2 (COVID-19) NSP12 antibody can be stored at 4°C for three months and -20°C, stable for up to one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.
-
-
: "Restriction of SARS-CoV-2 replication by targeting programmed -1 ribosomal frameshifting." in: Proceedings of the National Academy of Sciences of the United States of America, Vol. 118, Issue 26, (2021) (PubMed).
-
: "Restriction of SARS-CoV-2 replication by targeting programmed -1 ribosomal frameshifting." in: Proceedings of the National Academy of Sciences of the United States of America, Vol. 118, Issue 26, (2021) (PubMed).
-
- 抗原
- SARS-CoV-2 NSP12 (RdRP) (SARS-CoV-2 RdRP) (SARS-CoV-2 RNA-dependent RNA Polymerase (NSP12) (SARS-CoV-2 RdRP))
- 别名
- SARS-CoV-2 NSP12 (SARS-CoV-2 RdRP 产品)
- 别名
- pp1ab antibody, ORF1a polyprotein;ORF1ab polyprotein antibody, ORF1ab antibody
- 物质类
- Viral Protein
- 背景
- Coronavirus disease 2019 (COVID-19), formerly known as 2019-nCoV acute respiratory disease, is an infectious disease caused by SARS-CoV-2, a virus closely related to the SARS virus (1). The disease is the cause of the 2019-20 coronavirus outbreak (2). The structure of 2019-nCoV consists of the following: a spike protein (S), hemagglutinin-esterease dimer (HE), a membrane glycoprotein (M), an envelope protein (E) a nucleoclapid protein (N) and RNA. NSP12 interacts with nsp7 and nsp8.
- 基因ID
- 43740578
- UniProt
- P0DTC1
-
You are here:
